These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 26319093)
1. Predicted Indirectly ReCognizable HLA Epitopes Class I Promote Antileukemia Responses after Cord Blood Transplantation: Indications for a Potential Novel Donor Selection Tool. Thus KA; de Hoop TA; de Weger RA; Bierings MB; Boelens JJ; Spierings E Biol Blood Marrow Transplant; 2016 Jan; 22(1):170-3. PubMed ID: 26319093 [TBL] [Abstract][Full Text] [Related]
2. Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopes. Thus KA; Ruizendaal MT; de Hoop TA; Borst E; van Deutekom HW; Te Boome L; Kuball J; Spierings E Biol Blood Marrow Transplant; 2014 Nov; 20(11):1705-10. PubMed ID: 24980111 [TBL] [Abstract][Full Text] [Related]
3. Donor selection in a pediatric stem cell transplantation cohort using PIRCHE and HLA-DPB1 typing. Stenger W; Künkele A; Niemann M; Todorova K; Pruß A; Schulte JH; Eggert A; Oevermann L Pediatr Blood Cancer; 2020 Mar; 67(3):e28127. PubMed ID: 31850671 [TBL] [Abstract][Full Text] [Related]
4. Predicted indirectly recognizable HLA epitopes are not associated with clinical outcomes after haploidentical hematopoietic stem cell transplantation. Huo MR; Li D; Chang YJ; Xu LP; Zhang XH; Liu KY; Huang XJ Hum Immunol; 2018 Feb; 79(2):117-121. PubMed ID: 29155367 [TBL] [Abstract][Full Text] [Related]
5. The Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Score for HLA Class I Graft-versus-Host Disparity Is Associated with Increased Acute Graft-versus-Host Disease in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide. Rimando J; Slade M; DiPersio JF; Westervelt P; Gao F; Liu C; Romee R Biol Blood Marrow Transplant; 2020 Jan; 26(1):123-131. PubMed ID: 31563575 [TBL] [Abstract][Full Text] [Related]
6. Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations. Geneugelijk K; Thus KA; van Deutekom HWM; Calis JJA; Borst E; Keşmir C; Oudshoorn M; van der Holt B; Meijer E; Zeerleder S; de Groot MR; von dem Borne PA; Schaap N; Cornelissen J; Kuball J; Spierings E Front Immunol; 2019; 10():880. PubMed ID: 31068946 [TBL] [Abstract][Full Text] [Related]
7. PIRCHE-II Is Related to Graft Failure after Kidney Transplantation. Geneugelijk K; Niemann M; Drylewicz J; van Zuilen AD; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Hack CE; van Reekum FE; Verhaar MC; Kamburova EG; Bots ML; Seelen MAJ; Sanders JS; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MGJ; Vanderlocht J; Voorter CE; Wieten L; van Duijnhoven EM; Gelens M; Christiaans MHL; van Ittersum FJ; Nurmohamed A; Lardy JNM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Otten HG; Spierings E Front Immunol; 2018; 9():321. PubMed ID: 29556227 [TBL] [Abstract][Full Text] [Related]
8. Predicted Indirectly ReCognizable HLA Epitopes (PIRCHE) Are Associated with Poorer Outcome after Single Mismatch Unrelated Donor Stem Cell Transplantation: A Study of the Cooperative Transplant Study Group (KTS) of the German Group for Bone Marrow and Stem Cell Transplantation (DAG-KBT). Ayuk F; Bornhäuser M; Stelljes M; Zabelina T; Wagner EM; Schmid C; Christopeit M; Guellstorf M; Kröger N; Bethge W Transfus Med Hemother; 2019 Oct; 46(5):370-375. PubMed ID: 31832062 [TBL] [Abstract][Full Text] [Related]
9. Complete donor chimerism is a prerequisite for the effect of Predicted Indirectly ReCognizable HLA Epitopes (PIRCHE) on acute graft-versus-host disease. Thus KA; de Weger RA; de Hoop TA; Boers Trilles VE; Kuball J; Spierings E Chimerism; 2014; 5(3-4):94-8. PubMed ID: 26669207 [TBL] [Abstract][Full Text] [Related]
10. Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis. Chen YH; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Huang XJ; Liu KY Chin Med J (Engl); 2013 Jul; 126(13):2499-503. PubMed ID: 23823825 [TBL] [Abstract][Full Text] [Related]
12. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568 [TBL] [Abstract][Full Text] [Related]
13. Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation. Baron F; Labopin M; Ruggeri A; Mohty M; Sanz G; Milpied N; Bacigalupo A; Rambaldi A; Bonifazi F; Bosi A; Sierra J; Yakoub-Agha I; Santasusana JM; Gluckman E; Nagler A J Hematol Oncol; 2015 Oct; 8():107. PubMed ID: 26445106 [TBL] [Abstract][Full Text] [Related]
14. Comparison of unrelated cord blood transplantation and HLA-mismatched unrelated bone marrow transplantation for adults with leukemia. Atsuta Y; Morishima Y; Suzuki R; Nagamura-Inoue T; Taniguchi S; Takahashi S; Kai S; Sakamaki H; Kouzai Y; Kobayashi N; Fukuda T; Azuma H; Takanashi M; Mori T; Tsuchida M; Kawase T; Kawa K; Kodera Y; Kato S; Biol Blood Marrow Transplant; 2012 May; 18(5):780-7. PubMed ID: 22008851 [TBL] [Abstract][Full Text] [Related]
15. Exploring predicted indirectly recognizable HLA epitopes (PIRCHE-II) in liver transplant recipients on calcineurin inhibitor-free maintenance immunosuppression. A retrospective single center study. Meszaros M; Niemann M; Ursic-Bedoya J; Faure S; Meunier L; Rivière B; Costes-Martineau V; Thevenin C; Pageaux GP Transpl Immunol; 2020 Apr; 59():101272. PubMed ID: 32061667 [TBL] [Abstract][Full Text] [Related]
16. [Unrelated cord blood transplantation for the treatment of hematological malignancies]. Ren HY; Zhang YC; Huang XJ; Xu LP; Liu KY; Li D; Guo NL; Lu DP Zhonghua Xue Ye Xue Za Zhi; 2003 Feb; 24(2):82-5. PubMed ID: 12697102 [TBL] [Abstract][Full Text] [Related]
17. Dynamic Detection of Anti-Human Leukocyte Antigen (HLA) Antibodies but not HLA-DP Loci Mismatches Can Predict Acute Graft-versus-Host Disease and Overall Survival in HLA 12/12-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies. Pan Z; Yuan X; Li Y; Wu X; Zhu W; Bao X; Zhao Q; He J Biol Blood Marrow Transplant; 2016 Jan; 22(1):86-95. PubMed ID: 26283096 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk Index. Bashey A; Zhang X; Jackson K; Brown S; Ridgeway M; Solh M; Morris LE; Holland HK; Solomon SR Biol Blood Marrow Transplant; 2016 Jan; 22(1):125-33. PubMed ID: 26359881 [TBL] [Abstract][Full Text] [Related]
19. Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trial. Rio B; Chevret S; Vigouroux S; Chevallier P; Fürst S; Sirvent A; Bay JO; Socié G; Ceballos P; Huynh A; Cornillon J; Françoise S; Legrand F; Yakoub-Agha I; Michel G; Maillard N; Margueritte G; Maury S; Uzunov M; Bulabois CE; Michallet M; Clement L; Dauriac C; Bilger K; Gluckman E; Ruggeri A; Buzyn A; Nguyen S; Simon T; Milpied N; Rocha V; Biol Blood Marrow Transplant; 2015 Mar; 21(3):445-53. PubMed ID: 25460357 [TBL] [Abstract][Full Text] [Related]
20. The number of T cell allo-epitopes associates with CD4+ and CD8+ T-cell infiltration in pediatric cutaneous GVHD. Thus KA; van Halteren AG; de Hond TA; van Dijk MR; Kloos RQ; Lankester AC; Bierings MB; Spierings E Cell Immunol; 2015 Jun; 295(2):112-7. PubMed ID: 25880102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]